| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Granisetron Hydrochloride | Kaitril Tablets 1 mg (Granisetron Hydrochloride) | Film-coated tablet | Supply Shortage | 2026-03-17 |
| Ramipril, Felodipine | Triafin Tablets 2.5/2.5 mg | Film-coated tablet | Discontinued | 2026-03-16 |
| Magnesium sulfate hydrate | Magnesium Sulfate Hydrate Injection | Solution for Injection | Supply Shortage | 2026-03-12 |
| Inactivated Influenza Virus Antigen Type B Tablets [B/Austria/1359417/2021 BVR-26], Purified Inactivated Influenza Virus Antigen Type A [A/Victoria/4897/2022 IVR-238(H1N1)], Purified Inactivated Influenza Virus Antigen Type B [B/Phuket/3073/2013 BVR-1B],Purified inactivated influenza virus antigen type A [A/Croatia/10136RV/2023 X-425A(H3N2)] | FluadQuad Prefilled Syringe (Influenza Surface Antigen with MF59C.1 Adjuvant Vaccine) | Suspension for Injection | Discontinued | 2026-03-12 |
| Fluticasone propionate (unclassified), Vilanterol trifenatate (unclassified), Umeclidinium bromide (unclassified) | Trelige Ellipta | Metered-dose inhaler, powder | Supply Shortage | 2026-03-12 |
| White Vaseline | Sungkwang Sterile Vaseline Gauze (White Vaseline) | Drug-impregnated gauze | Discontinued | 2026-03-11 |
| Benzidamine hydrochloride, cetylpyridinium chloride hydrate | Mogul One-Q Spray | Oral Solution | Supply Shortage | 2026-03-11 |
| Lidocaine, Acrylonol hydrate | Sungkwang Lidocaine Gargle | Patch with carrier | Discontinued | 2026-03-11 |
| Acyclovir | Citavic Oral Adhesive Tablets (Acyclovir) | Adhesive tablet | Discontinued | 2026-03-05 |
| Allergen extract | Novohylen Depot Maintenance Treatment A | Solution for Injection | Discontinued | 2026-03-04 |
| Allergen extract | Novohylen Depot Initial Treatment A | Solution for Injection | Discontinued | 2026-03-04 |
| Milnacipran Hydrochloride | Ixel Capsules 12.5 mg (Milnacipran Hydrochloride) | Hard capsule, acid-soluble | Discontinued | 2026-03-04 |
| Active ingredients | Status | Update | Specialty |
| dipyridamole | Supply tension | 20/03/2026 | Persantine 10 mg/2 mL, solution for injection, ampoule |
| triamcinolone hexacetonide | Return to availability | 19/03/2026 | Hexatrione 2%, injectable suspension (intra-articular) |
| aprepitant | Stock shortage | 19/03/2026 | Emend 125 mg, powder for oral suspension |
| medroxyprogesterone | Supply tension | 17/03/2026 | Depo-Prodasone 500 mg, injectable suspension |
| olipudase alfa | Supply tension | 17/03/2026 | Xenpozyme 20 mg, powder for solution for infusion |
| momelotinib (dihydrochloride) | Supply tension | 16/03/2026 | Omjjara 100 mg, film-coated tablet |
| sodium avibactam, aztreonam | Supply tension | 16/03/2026 | Emblaveo 1.5 g/0.5 g, powder for solution for infusion |
| human von Willebrand factor | Supply tension | 16/03/2026 | Wilfactin 100 IU/mL, powder and solvent for solution for injection |
| mesalazine | Stock shortage | 16/03/2026 | Fivasa 400 mg, enteric-coated tablet |
| Active ingredients |
| Date of last report | Type of reason | AM designation | |
| Fosfomycin sodium (Ph. Eur.) | Change notification | 20.03.2026 | Production issue | Fosfomycin Eberth 4 g powder for solution for infusion | |
| Fosfomycin sodium (Ph. Eur.) | Change notification | 20.03.2026 | Production issue | Fosfomycin Eberth 2 g powder for solution for infusion | |
| Ivermectin | Change notification | 20.03.2026 | Other | DRIPONIN 3 mg tablets | |
| Gabapentin | Initial notification | 19.03.2026 | Other | Gabapentin Aurobindo 400 mg hard capsules | |
| Gabapentin | Initial notification | 19.03.2026 | Other | Gabapentin Aurobindo 600 mg film-coated tablets | |
| Sultiam | Initial notification | 19.03.2026 | Production issue | Sultiam-neuraxpharm 100 mg film-coated tablets | |
| Sultiam | Initial notification | 19.03.2026 | Production issue | Sultiam-neuraxpharm 50 mg film-coated tablets | |
| Pramipexole dihydrochloride monohydrate | Change notification | 19.03.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg extended-release tablets | |
| Rizatriptan benzoate | Change notification | 19.03.2026 | Production issue | Rizatriptan Glenmark 5 mg orodispersible tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 19.03.2026 | Production issue | Quetiapine HEXAL 50 mg extended-release tablets | |
| Rizatriptan benzoate | Change notification | 19.03.2026 | Production issue | Rizatriptan Glenmark 5 mg tablets | |
| Ipratropium bromide (Ph.Eur.); Salbutamol sulfate | Change notification | 19.03.2026 | Production issue | COMBIPRASAL 0.5 mg / 2.5 mg solution for a nebulizer | |
| Galantamine hydrobromide | Change notification | 19.03.2026 | Other | Galantamine – 1A Pharma 8 mg extended-release hard capsules | |
| Galantamine hydrobromide | Change notification | 19.03.2026 | Other | Galantamine – 1A Pharma 16 mg extended-release hard capsules | |
| Abiraterone acetate | Change notification | 19.03.2026 | Other | Abiraterone HEXAL 1000 mg film-coated tablets | |
| Thioctic acid trometamol salt (1:1) | Change notification | 19.03.2026 | Other | Thioctacid 600 T | |
| Nifedipine | Initial notification | 19.03.2026 | Other | Nifedipine Denk 20 mg extended-release | |
| Rivastigmine hydrochloride | Initial notification | 18.03.2026 | Other | Rivastigmine Aurobindo 3 mg hard capsules | |
| Rivastigmine hydrochloride | Initial notification | 18.03.2026 | Other | Rivastigmine Aurobindo 1.5 mg hard capsules | |
| Rifabutin | Change notification | 18.03.2026 | Other | Mycobutin | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 18.03.2026 | Other | Quetiapine AL 50 mg extended-release tablets | |
| Cytarabine | Change notification | 18.03.2026 | Production issue | ARA-cell 4000 mg solution for infusion | |
| Cytarabine | Change notification | 18.03.2026 | Production issue | ARA-cell 1000 mg solution for infusion | |
| Interferon gamma-1b | Initial notification | 18.03.2026 | Production issue | IMUKIN | |
| Telmisartan | Change notification | 18.03.2026 | Other | Telmisartan Micro Labs 20 mg tablets | |
| Atorvastatin calcium trihydrate (Ph. Eur.) | Change notification | 18.03.2026 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets | |
| Pramipexole dihydrochloride monohydrate | Change notification | 18.03.2026 | Production issue | Pramipexole STADA 0.52 mg extended-release tablets | |
| Aprepitant | Change notification | 18.03.2026 | Production issue | Aprepitant STADA 80 mg hard capsules | |
| Escitalopram oxalate | Change notification | 18.03.2026 | Production issue | Escitalopram STADA 20 mg film-coated tablets | |
| Levofloxacin hemihydrate | Change notification | 17.03.2026 | Production issue | Levofloxacin Kabi 5 mg/mL solution for infusion | |
| Vancomycin hydrochloride | Initial notification | 17.03.2026 | Other | Vancomycin “Lederle” 500 mg | |
| Clonidine hydrochloride | Change notification | 17.03.2026 | Production issue | Clonistada 0.15 mg tablets | |
| Ethambutol dihydrochloride | Change notification | 17.03.2026 | Production issue | EMB-FATOL 400 mg | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 17.03.2026 | Other | Seroquel Prolong 50 mg extended-release tablets | |
| Isosorbide mononitrate | Initial notification | 17.03.2026 | Production issue | Ismo Retard | |
| Gabapentin | Initial notification | 16.03.2026 | Other | Gabapentin Glenmark 800 mg film-coated tablets | |
| Gabapentin | Initial notification | 16.03.2026 | Other | Gabapentin Glenmark 600 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 16.03.2026 | Production issue | Quetiapine Glenmark 150 mg extended-release tablets | |
| Galantamine hydrobromide | Change notification | 16.03.2026 | Production issue | Galantamine Glenmark 8 mg extended-release hard capsules | |
| Ezetimibe; Simvastatin | Change notification | 16.03.2026 | Production issue | Ezetimibe/Simvastatin Glenmark 10 mg/10 mg tablets | |
| Rifampicin | Change notification | 16.03.2026 | Production issue | EREMFAT 450 mg | |
| Minocycline hydrochloride dihydrate (Ph. Eur.) | Change notification | 16.03.2026 | Production issue | Skid 100 mg | |
| Minocycline hydrochloride dihydrate (Ph. Eur.) | Change notification | 16.03.2026 | Production issue | Skid 50 mg | |
| Aprepitant | Change notification | 16.03.2026 | Production issue | Aprepitant Zentiva 80 mg hard capsules | |
| Aprepitant | Change notification | 16.03.2026 | Production issue | Aprepitant Zentiva 125 mg hard capsules | |
| Aprepitant | Change notification | 16.03.2026 | Production issue | Aprepitant Zentiva 80 mg and 125 mg hard capsules | |
| Rifampicin Sodium | Change notification | 16.03.2026 | Other | Eremfat IV 600 mg | |
| Trandolapril; Verapamil hydrochloride | Change notification | 16.03.2026 | Other | Tarka 180 mg/2 mg modified-release tablets |
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
| atomoxetine hydrochloride | Capsule, hard | 11.43 mg | Resolved | Available | Manufacturing | 23/03/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Unavailable | Commercial Changes / Commercial viability | 23/03/2026 |
| primaquine phosphate | Tablet, uncoated | 13.2 mg | Current | Emergency Supply Only | Manufacturing | 23/03/2026 |
| tamoxifen citrate | Tablet | 30.34 mg | Current | Limited Availability | Manufacturing | 23/03/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 23/03/2026 |
| moxonidine | Tablet, film coated | 200 microgram | Anticipated | Available | Manufacturing | 23/03/2026 |
| methotrexate | Tablet | 2.5 mg | Current | Limited Availability | Manufacturing | 23/03/2026 |
| levothyroxine sodium | Tablet, uncoated | .2 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 23/03/2026 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| chlorpromazine hydrochloride | Oral Liquid | 5 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 20/03/2026 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Resolved | Available | Manufacturing | 20/03/2026 |
| ifosfamide | Injection, powder for | 2 g | Current | Limited Availability | Manufacturing | 20/03/2026 |
| tobramycin | Capsule, hard | 28 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| daunorubicin hydrochloride | Injection, powder for | 20 mg | Resolved | Available | Manufacturing | 20/03/2026 |
| nitrofurantoin | Capsule, hard | 50 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| irbesartan | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| phenobarbital sodium | Injection, solution | 219 mg/mL | Anticipated | Available | Manufacturing | 20/03/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Current | Limited Availability | Manufacturing | 20/03/2026 |
| tadalafil | Tablet, film coated | 20 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Resolved | Available | Manufacturing | 20/03/2026 |
| risperidone | Tablet, film coated | 3 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| rasagiline mesilate | Tablet | 1.56 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| lacosamide | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| phenobarbital | Tablet, uncoated | 30 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| prazosin hydrochloride | Tablet, uncoated | 1.1 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| lacosamide | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 20/03/2026 |
| prazosin hydrochloride | Tablet, uncoated | 5.5 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| gliclazide | Tablet, uncoated | 80 mg | Current | Limited Availability | Manufacturing | 20/03/2026 |
| risperidone | Tablet, film coated | .5 mg | Anticipated | Available | Manufacturing | 20/03/2026 |
| Hepatitis B surface antigen recombinant | Injection, suspension | 40 microgram/mL | Current | Limited Availability | Unexpected increase in consumer demand | 20/03/2026 |
| prazosin hydrochloride | Tablet, uncoated | 1.095 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/03/2026 |
| imipramine hydrochloride | Tablet, sugar coated | 10 mg | Current | Limited Availability | Manufacturing | 20/03/2026 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Resolved | Available | Manufacturing | 20/03/2026 |
| prazosin hydrochloride | Tablet, uncoated | 2.2 mg | Current | Unavailable | Manufacturing | 20/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| candesartan cilexetil~hydrochlorothiazide | Tablet, uncoated | 16 mg~12.5 mg | Current | Limited Availability | Manufacturing | 19/03/2026 |
| aztreonam | Injection, powder for | 1 g | Anticipated | Available | Manufacturing | 19/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| vinorelbine tartrate | Injection, concentrated | 13.85 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 19/03/2026 |
| insulin | Injection, suspension | 100 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| candesartan cilexetil~hydrochlorothiazide | Tablet | 32 mg~25 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| insulin | Injection, suspension | 100 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| insulin | Injection, solution | 100 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| flecainide acetate | Tablet | 50 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 19/03/2026 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| candesartan cilexetil | Tablet, uncoated | 8 mg | Anticipated | Available | Manufacturing | 19/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.844 mg | Current | Limited Availability | Manufacturing | 19/03/2026 |
| candesartan cilexetil | Tablet, uncoated | 32 mg | Anticipated | Available | Manufacturing | 19/03/2026 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Anticipated | Available | Manufacturing | 19/03/2026 |
| glatiramer acetate | Injection, solution | 40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| pravastatin sodium | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 19/03/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| Rabies virus | Injection, powder for | 2.5 IU | Anticipated | Available | Manufacturing | 19/03/2026 |
| pravastatin sodium | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 19/03/2026 |
| glatiramer acetate | Injection, solution | 40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 19/03/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 19/03/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Limited Availability | Manufacturing | 19/03/2026 |
| cisatracurium besilate | Injection, solution | 2.68 mg/mL | Resolved | Available | Manufacturing | 19/03/2026 |
| Insulin lispro | Injection, solution | 100 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/03/2026 |
| tadalafil | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 19/03/2026 |
| lamotrigine | Tablet | 200 mg | Resolved | Available | Manufacturing | 19/03/2026 |
| levothyroxine sodium | Tablet, uncoated | 50 microgram | Current | Unavailable | Manufacturing | 18/03/2026 |
| lidocaine | Spray, solution | 100 mg/mL | Resolved | Available | Manufacturing | 18/03/2026 |
| lamotrigine | Tablet | 100 mg | Resolved | Available | Manufacturing | 18/03/2026 |
| sevelamer carbonate | Tablet, film coated | 800 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/03/2026 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Current | Limited Availability | Manufacturing | 18/03/2026 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Current | Limited Availability | Manufacturing | 18/03/2026 |
| nizatidine | Capsule | 300 mg | Current | Limited Availability | Manufacturing | 18/03/2026 |
| Thyrotropin alfa | Injection, powder for | 1.1 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 18/03/2026 |
| simvastatin~ezetimibe | Tablet | 40 mg~10 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 18/03/2026 |
| propofol | Injection, intravenous infusion | 10 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 18/03/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~80 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 18/03/2026 |
| levothyroxine sodium | Tablet, uncoated | 100 microgram | Current | Unavailable | Manufacturing | 18/03/2026 |
| promethazine hydrochloride | Injection, solution | 25 mg/mL | Anticipated | Available | Manufacturing | 18/03/2026 |
| bortezomib | Injection, solution | 3.5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 18/03/2026 |
| levothyroxine sodium | Tablet, uncoated | 200 microgram | Current | Unavailable | Manufacturing | 18/03/2026 |
| anastrozole | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 18/03/2026 |
| levothyroxine sodium | Tablet, uncoated | 75 microgram | Current | Unavailable | Manufacturing | 18/03/2026 |
| entacapone~carbidopa monohydrate~levodopa | Tablet, film coated | 200 mg~27 mg~100 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 18/03/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 18/03/2026 |
| sugammadex sodium | Injection, solution | 217.6 mg | Current | Unavailable | Commercial Changes / Commercial viability | 18/03/2026 |
| crisaborole | Ointment | 2 % w/w | Resolved | Available | Unexpected increase in consumer demand | 18/03/2026 |
| vancomycin hydrochloride | Capsule, hard | 268 mg | Anticipated | Available | Manufacturing | 17/03/2026 |
| clonidine hydrochloride | Injection, solution | 150 microgram/mL | Current | Unavailable | Unexpected increase in consumer demand | 17/03/2026 |
| ketorolac trometamol | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 17/03/2026 |
| ibandronate sodium | Tablet, film coated | 56.25 mg | Current | Limited Availability | Manufacturing | 17/03/2026 |
| diclofenac sodium | Tablet, enteric coated | 25 mg | Anticipated | Available | Manufacturing | 17/03/2026 |
| oxycodone hydrochloride | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 17/03/2026 |
| levothyroxine sodium | Tablet | 50 microgram | Resolved | Available | Commercial Changes / Commercial viability | 17/03/2026 |
| levothyroxine sodium | Tablet | 75 microgram | Resolved | Available | Commercial Changes / Commercial viability | 17/03/2026 |
| quetiapine fumarate | Tablet, modified release | 345 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/03/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Resolved | Available | Manufacturing | 17/03/2026 |
| formoterol fumarate | Inhalation, powder for | 12 microgram | Resolved | Available | Manufacturing | 17/03/2026 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/03/2026 |
| quetiapine fumarate | Tablet, film coated | 345.36 mg | Anticipated | Available | Manufacturing | 17/03/2026 |
| hydralazine hydrochloride | Injection, powder for | 20 mg | Current | Unavailable | Manufacturing | 17/03/2026 |
| aripiprazole | Tablet, uncoated | 15 mg | Resolved | Available | Manufacturing | 17/03/2026 |
| nimodipine | Tablet, film coated | 30 mg | Current | Unavailable | Manufacturing | 17/03/2026 |
| glimepiride | Tablet, uncoated | 1 mg | Resolved | Available | Manufacturing | 17/03/2026 |
| furosemide | Injection, solution | 20 mg | Anticipated | Available | Manufacturing | 17/03/2026 |
| cyclophosphamide monohydrate | Injection, powder for | 2.138 g | Current | Limited Availability | Manufacturing | 17/03/2026 |
| olipudase alfa | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 17/03/2026 |
| ceftazidime pentahydrate | Injection, powder for | 1.164 g | Current | Limited Availability | Unexpected increase in consumer demand | 17/03/2026 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Resolved | Available | Manufacturing | 16/03/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 126.83 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| eplerenone | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| olmesartan medoxomil~amlodipine besilate | Tablet, film coated | 20 mg~6.935 mg | Current | Unavailable | Manufacturing | 16/03/2026 |
| estradiol hemihydrate | Drug delivery system, transdermal | 1.54 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/03/2026 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| desmopressin acetate | Spray, solution | .1 mg/mL | Current | Unavailable | Product recall | 16/03/2026 |
| estradiol | Drug delivery system, transdermal | .585 mg | Resolved | Available | Manufacturing | 16/03/2026 |
| aprepitant | Capsule | 165 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| aripiprazole | Tablet, uncoated | 20 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/03/2026 |
| fludarabine phosphate | Injection, powder for | 50 mg | Current | Unavailable | Manufacturing | 16/03/2026 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 16/03/2026 |
| sodium chloride | Injection, solution | .45 g | Current | Unavailable | Commercial Changes / Commercial viability | 16/03/2026 |
| amikacin sulfate | Injection, solution | 333.76 mg/mL | Current | Unavailable | Manufacturing | 16/03/2026 |
| midodrine hydrochloride | Tablet | 5 mg | Current | Unavailable | Manufacturing | 16/03/2026 |
| indapamide hemihydrate | Tablet, modified release | 1.5 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| sacubitril~valsartan | Tablet, film coated | 24.3 mg~25.7 mg | Current | Unavailable | Manufacturing | 16/03/2026 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .75 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| carbetocin | Injection, solution | 100 microgram/mL | Current | Unavailable | Manufacturing | 16/03/2026 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 16/03/2026 |
| desmopressin acetate | Spray, solution | 10 microgram/actuation | Current | Limited Availability | Manufacturing | 16/03/2026 |
| mirtazapine | Tablet, orally disintegrating | 45 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| mirtazapine | Tablet, orally disintegrating | 15 mg | Anticipated | Available | Manufacturing | 16/03/2026 |
| sugammadex sodium | Injection, solution | 217.6 mg | Current | Limited Availability | Manufacturing | 16/03/2026 |
| drospirenone~ethinylestradiol | Tablet | 3 mg~30 microgram | Resolved | Available | Manufacturing | 16/03/2026 |
| rosuvastatin calcium | Tablet, film coated | 20.84 mg | Resolved | Available | Manufacturing | 16/03/2026 |
| Generic Name | Shortage Status | Revision Date |
| Epoprostenol Injection | Current Shortages | 20-Mar-26 |
| Hydrocodone and Acetaminophen Tablets | Current Shortages | 20-Mar-26 |
| Lidocaine 5% Transdermal Patch | Current Shortages | 20-Mar-26 |
| Linezolid Injection | Current Shortages | 20-Mar-26 |
| Metyrosine Capsules | Current Shortages | 20-Mar-26 |
| Penicillin V Potassium Oral Presentations | Current Shortages | 20-Mar-26 |
| Theophylline 24-Hour Extended Release Capsules and Tablets | Current Shortages | 20-Mar-26 |
| Benzylpenicilloyl Polylysine | Current Shortages | 19-Mar-26 |
| Fludarabine Injection | Current Shortages | 19-Mar-26 |
| Methylphenidate Transdermal System | Resolved Shortages | 19-Mar-26 |
| Amiodarone Injection | Current Shortages | 17-Mar-26 |
| Dulaglutide Injection | Current Shortages | 17-Mar-26 |
| Insulin Premixed Solution for Injection (Myxredlin) | Current Shortages | 17-Mar-26 |
| Dobutamine Injection | Current Shortages | 16-Mar-26 |
| Dopamine Hydrochloride Injection | Current Shortages | 16-Mar-26 |
| Vancomycin Hydrochloride Injection | Current Shortages | 16-Mar-26 |
March 19, 2026
March 18, 2026
March 17, 2026
March 16, 2026
